{
    "title": "Allergan assuages shareholder fears over losing Restasis patent",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-5038903/Allergan-beats-earnings-estimates-medical-aesthetics-strength.html",
    "date": "2017-11-01",
    "keywords": [
        "year",
        "restasis",
        "drug",
        "drugmaker",
        "percent",
        "business",
        "stock",
        "company",
        "quarter",
        "share",
        "erman",
        "tamara",
        "month",
        "treatment",
        "planning",
        "deal",
        "allergan",
        "charge",
        "revenue",
        "coolsculpting",
        "plc",
        "wednesday",
        "growth",
        "patent",
        "secondmost",
        "dryeye",
        "afternoon",
        "trading",
        "competition",
        "base",
        "strategy",
        "something",
        "chief",
        "executive",
        "brent",
        "conference",
        "call",
        "tribe",
        "september",
        "review",
        "ire",
        "judge",
        "market",
        "ruling",
        "result",
        "court",
        "order",
        "competitor",
        "impact",
        "regardless",
        "day",
        "june",
        "value",
        "kedra",
        "healthcare",
        "analyst",
        "amp",
        "co",
        "loss",
        "profit",
        "estimate",
        "thomson",
        "botox",
        "medicine",
        "acquisition",
        "lifecell",
        "april",
        "zeltiq",
        "half",
        "companys",
        "reporting",
        "york",
        "bengaluru",
        "editing",
        "orlofsky",
        "lisa",
        "shumaker"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}